Daniel Grizelj/DigitalVision via Getty Images Sanofi ( SNY ) is an established pharmaceutical company with an historic capitalisation of around $120B. The share price recently experienced a sharp decline of 10% compared to its historical price due to several setbacks in drugs currently in clinical stage . Their main product, Dupixent, is facing a patent cliff with an expiration date starting in 20...
Daniel Grizelj/DigitalVision via Getty Images Sanofi ( SNY ) is an established pharmaceutical company with an historic capitalisation of around $120B. The share price recently experienced a sharp decline of 10% compared to its historical price due to several setbacks in drugs currently in clinical stage . Their main product, Dupixent, is facing a patent cliff with an expiration date starting in 2030. In this review, we propose a projection of the revenue of Dupixent for each of its indications. We next provide a quantitative approach to find the part of Dupixent's revenue in the market capitalisation of the company. Finally, we will conclude that the stock is an Hold depending on risk tolerance of the investor. About Dupixent Dupixent (dupilumab) is a fully human monoclonal antibody that inhibits interleukin-4 (IL-4) and interleukin-13 (IL-13) signalling by specifically binding to the IL-4Rα subunit shared by the IL-4 and IL-13 receptor complexes. By blocking these key drivers of type 2 inflammation, Dupixent helps to reduce inflammatory responses in multiple diseases. The drug is currently approved worldwide for several indications including moderate-to-severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), chronic obstructive pulmonary disease (COPD), eosinophilic esophagitis (EoE), and prurigo nodularis. In the new and incoming approval we can cite bullous pemphigoïd, chronic spontaneous urticaria or allergic fungal rhinosinusitis. As a general indication, according to third party sources , the current revenue breakdown is as follow: 65% atopic dermatitis, 20% asthma, 10% CRSwNP, 5% COPD, 1% EoE and prurigo. Atopic Dermatitis About the market Atopic dermatitis (AD) is a chronic inflammatory skin disease. Global prevalence was estimated at around 2.6% representing around 200M patients. Among patients, 36.2% were presenting moderate AD and 18.2% had severe AD. This creates a total addressable market of 64.4M of patients. In practice...
(RTTNews) - FedEx Corporation (FDX) will host a conference call at 5:30 PM ET on March 19, 2026, to discuss Q3 26 earnings results. To access the live webcast, log on to https://investors.fedex.com/news-and-events/webcasts-and-presentations/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
(RTTNews) - FedEx Corporation (FDX) will host a conference call at 5:30 PM ET on March 19, 2026, to discuss Q3 26 earnings results. To access the live webcast, log on to https://investors.fedex.com/news-and-events/webcasts-and-presentations/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
A recession mindset took hold among global investors after strikes on energy infrastructure in the Middle East heightened fears that disruption to production and distribution would keep oil prices elevated for longer, darkening the global economic outlook. Crude prices staged a comeback on Thursday after Iran attacked a liquefied petroleum gas site in Qatar in retaliation for Israel’s strikes on i...
A recession mindset took hold among global investors after strikes on energy infrastructure in the Middle East heightened fears that disruption to production and distribution would keep oil prices elevated for longer, darkening the global economic outlook. Crude prices staged a comeback on Thursday after Iran attacked a liquefied petroleum gas site in Qatar in retaliation for Israel’s strikes on its South Pars gas field. Brent futures surged 5.5 per cent to US$113.53 a barrel in London, and contracts for West Texas Intermediate jumped 1 per cent to US$97.44. “The attack on Qatari gas fields has taken the Gulf crisis to a more dangerous level for the global economy,” said Gary Dugan, CEO of The Global CIO Office, which advises family offices and ultra-high-net-worth investors. “Disruption to both oil and gas supplies is pushing prices higher and raises the risk of genuine fuel shortages that could materially crimp global growth.” Advertisement The outlook triggered a broad risk-off mode among investors, as the narrative following the closure of the Strait of Hormuz quickly shifted from energy shortage to supply disruption. The US dollar index held up firmly at around 100, indicating investors were looking for safe havens, while stock markets saw sell-offs. After the S&P 500 sank 1.4 per cent overnight, the Hang Seng Index slid 2 per cent on Thursday, while the Shanghai Composite Index of yuan-denominated stocks closed 1.4 per cent lower after briefly dropping below the 4,000-point threshold. Advertisement Meanwhile, the yield on longer-dated US Treasuries edged higher, reflecting fears of resurgent inflation. Gold also retreated, with investors taking profits to cover margin calls linked to other asset classes.
tomwachs/iStock via Getty Images Introduction I love value investing. And last year, I was an aggressive buyer of cyclical value stocks, which perfectly fit my growth-broadening thesis. With that said, I have used the word “value” twice in a different context so far in this article. “Value” is a very complex concept, as the definition tends to vary per investor. For some, value investing means buy...
tomwachs/iStock via Getty Images Introduction I love value investing. And last year, I was an aggressive buyer of cyclical value stocks, which perfectly fit my growth-broadening thesis. With that said, I have used the word “value” twice in a different context so far in this article. “Value” is a very complex concept, as the definition tends to vary per investor. For some, value investing means buying low P/E cigarette companies, car producers, and oil companies. That’s why it’s sometimes ridiculed. After all, why should someone buy an industrial company when they can buy a fancy semiconductor or software company? It’s just some silly example, yet one that tends to pop up over time, as it’s often a debate between low-growth value stocks versus high-growth stocks. That’s why I decided to do a number of things in this article, including giving you one of my favorite explanations of what value investing is about, why I think it’s superior going forward, and what I’m buying (real-life examples). So, as we have a lot to discuss, let’s keep this intro short and get right to it! Based On The Right Definition, I’m A Value Investor Most of you know that I’m not a typical dividend/value investor, as I own just 15 individual stocks with an average yield of a bit more than 1.0%. Four of my biggest five holdings, which account for roughly half of my portfolio, have a yield of less than 1%. Yet, I own no technology stocks and not a single company that one would classify as a “growth” stock. As I already briefly mentioned, for most investors, value stocks are companies trading at low valuations, often with poor sentiment. In other words, companies that are unloved. To some extent, that definition works. However, it wouldn’t do these companies much justice, as there’s way more to it. For starters, a P/E ratio in itself is just a tiny part of the story. For most, it’s simply the price divided by the earnings of the past four quarters/12 months. I often use a blended P/E ratio based o...
HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), a leading space technology, infrastructure, and services company, today announced its financial results for the fourth quarter and full-year ended December 31, 2025. Intuitive Machines CEO Steve Altemus said, “2025 was a transformational year for Intuitive Machines. We compl...
HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), a leading space technology, infrastructure, and services company, today announced its financial results for the fourth quarter and full-year ended December 31, 2025. Intuitive Machines CEO Steve Altemus said, “2025 was a transformational year for Intuitive Machines. We completed our second lunar mission, expanded into national security space programs, closed the acquisition of KinetX Aerospace, and announced the acquisition of Lanteris Space Systems. These acquisitions significantly expand our scale, addressable market, and growth opportunities.” Highlights Completed $800 million acquisition of Lanteris Space Systems in Q1 2026 to be a vertically integrated next-generation space prime contractor for commercial, civil and national security space initiatives Completed acquisition of KinetX to expand deep space navigation and constellation management capabilities, while accelerating delivery of secure data relay from the Moon to Mars Awarded to support SDA Proliferated Warfighter Space Architecture tranche 3 tracking layer, started production on tranche 2, and finishing customer delivery for tranche 1 Awarded a contract for the Missile Defense Agency SHIELD IDIQ with a ceiling of $151 billion; this contract encompasses a broad range of work areas that allows for the rapid delivery of innovative capabilities to the warfighter with increased speed and agility Launched EchoStar XXV in Q1 2026; completing final spacecraft checkouts and joins a fleet of over 100 spacecraft in orbit Secured $175 million strategic investment in Q1 2026 to advance satellite communications and in-space data processing capabilities Mr. Altemus continued, “Intuitive Machines intends to invest in expanding its Near Space Network Services and establish a solar system internet independent of Earth. Through investments in the Lanteris platforms, specifically the 1300 series, th...
Delivered record-high revenues, Adjusted EBITDA1, Adjusted EBITDA per share1 since inception Generated record high cash flow from operations since inception Provides 2026 revenues guidance of $490 million to $510 million and adjusted EBITDA1 of approximately 15% MONTREAL, March 19, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) spec...
Delivered record-high revenues, Adjusted EBITDA1, Adjusted EBITDA per share1 since inception Generated record high cash flow from operations since inception Provides 2026 revenues guidance of $490 million to $510 million and adjusted EBITDA1 of approximately 15% MONTREAL, March 19, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended December 31, 2025. All currency amounts are in thousands except for share and per share amounts. All currencies are Canadian unless otherwise specified. 2025 Highlights Financial results Revenues were $450,088, an increase of $78,784 or 21% over the prior year. The increase was primarily driven by the incremental revenues from the Paladin and Sumitomo Transactions and the growth of our key promoted products, partly offset by declines in our mature and branded generic products, the termination of a non-strategic agreement in Colombia and the impact of hyperinflation 2 . . Gross margin was 44% of revenues compared to 47% in prior year. The decrease was due to the impact of hyperinflation 2 and the fair value adjustment on the inventory acquired in the Paladin transaction. and the fair value adjustment on the inventory acquired in the Paladin transaction. Operating loss was $2,350 compared to an operating income of $7,397 in prior year. Net loss was $5,374, compared to a net income of $4,332 in prior year. Loss per share was $0.05, compared to an earnings per share of $0.04 in prior year. Cash inflow from operations was $68,957, an increase of $32,677 or 90% over prior year. Non-GAAP measures Adjusted Revenues 1 were $452,351, an increase of $86,939 or 24% or an increase of $87,855 or 24% on a constant currency 1 basis, primarily driven by the incremental revenues from the Paladin and Sumitomo Transactions and the growth of our key promoted products, partly offset by declines i...
Niveau record des produits des activités ordinaires, du BAIIA ajusté1 et du BAIIA ajusté par action1 depuis la création Niveau record des flux de trésorerie liés aux activités d’exploitation depuis la création Produits des activités ordinaires prévus de 490 millions de dollars à 510 millions de dollars et BAIIA ajusté1 prévu d’environ 15 % pour 2026 MONTRÉAL, 19 mars 2026 (GLOBE NEWSWIRE) -- Théra...
Niveau record des produits des activités ordinaires, du BAIIA ajusté1 et du BAIIA ajusté par action1 depuis la création Niveau record des flux de trésorerie liés aux activités d’exploitation depuis la création Produits des activités ordinaires prévus de 490 millions de dollars à 510 millions de dollars et BAIIA ajusté1 prévu d’environ 15 % pour 2026 MONTRÉAL, 19 mars 2026 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight » ou la « Société »), une société pharmaceutique spécialisée panaméricaine (hors États-Unis), a annoncé aujourd’hui ses résultats financiers pour le quatrième trimestre et l’exercice clos le 31 décembre 2025. Tous les montants sont exprimés en milliers de dollars canadiens (sauf indication contraire), à l’exception du nombre d’actions et des montants par action. Faits saillants de 2025 Résultats financiers Produits des activités ordinaires de 450 088 $, une augmentation de 78 784 $, ou 21 %, comparativement à ceux de l’exercice précédent. L’augmentation s’explique principalement par les produits des activités ordinaires différentiels tirés des transactions avec Paladin et Sumitomo et par la croissance de nos principaux produits promus, contrebalancées en partie par la diminution de nos produits à maturité et de nos produits génériques de marque, la résiliation d’une entente non stratégique en Colombie et l’incidence de l’hyperinflation 2 . . Marge brute de 44 % des produits des activités ordinaires, en comparaison à une marge brute de 47 % pour l’exercice précédent. La diminution s’explique par l’incidence de l’hyperinflation 2 et l’ajustement de la juste valeur des stocks acquis lors de la transaction avec Paladin. et l’ajustement de la juste valeur des stocks acquis lors de la transaction avec Paladin. Perte d’exploitation de 2 350 $, en comparaison d’un résultat d’exploitation de 7 397 $ pour l’exercice précédent. Perte nette de 5 374 $, par rapport à un profit net de 4 332 $ pour l’exercice précédent. Perte par action de 0,05 $...
JENA, Germany, March 19, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced its financial results for the three and twelve months ended December 31, 2025, and provided a business update.
JENA, Germany, March 19, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced its financial results for the three and twelve months ended December 31, 2025, and provided a business update.
Completed a strategic growth investment in the fourth quarter into Ability Insurance Company, significantly improving capital ratios and enabling expansion of its business
Completed a strategic growth investment in the fourth quarter into Ability Insurance Company, significantly improving capital ratios and enabling expansion of its business
(RTTNews) - 3M Co. (MMM), a provider of diversified technology services, on Thursday said it agreed to acquire Madison Fire & Rescue in partnership with Bain Capital Specialty Finance, Inc. (BCSF), for $1.95 billion and form a new joint venture focused on fire safety and rescue solutions. The transaction is expected to close in the second half of 2026. Under the agreement, 3M will contribute its S...
(RTTNews) - 3M Co. (MMM), a provider of diversified technology services, on Thursday said it agreed to acquire Madison Fire & Rescue in partnership with Bain Capital Specialty Finance, Inc. (BCSF), for $1.95 billion and form a new joint venture focused on fire safety and rescue solutions. The transaction is expected to close in the second half of 2026. Under the agreement, 3M will contribute its Scott Safety business to the venture, receive $700 million in cash proceeds at closing and hold a 50.1% stake, while Bain Capital will own 49.9%. The new entity will combine Scott Safety's self-contained breathing apparatus solutions with Madison Fire & Rescue's portfolio of rescue technology and fire suppression products. Madison Fire & Rescue offers products under brands including Holmatro, Amkus, Task Force Tips, Fire Fighting Systems and Waterax. On Wednesday, Bain Capital closed trading 0.32% lesser at $12.27 on the New York Stock Exchange. In the pre-market trading, 3M Co. is 0.19% lesser at $144.81 on the New York Stock Exchange. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Sunbelt Securities Inc. decreased its position in NVIDIA Corporation (NASDAQ:NVDA - Free Report) by 4.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 336,115 shares of the computer hardware maker's stock after selling 14,721 shares during the period. NVIDIA comprises 4.3% of Sunbelt Securi...
Sunbelt Securities Inc. decreased its position in NVIDIA Corporation (NASDAQ:NVDA - Free Report) by 4.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 336,115 shares of the computer hardware maker's stock after selling 14,721 shares during the period. NVIDIA comprises 4.3% of Sunbelt Securities Inc.'s portfolio, making the stock its 2nd largest holding. Sunbelt Securities Inc.'s holdings in NVIDIA were worth $62,712,000 at the end of the most recent quarter. A number of other institutional investors and hedge funds have also made changes to their positions in the company. Center for Financial Planning Inc. grew its holdings in NVIDIA by 4.6% during the 2nd quarter. Center for Financial Planning Inc. now owns 8,429 shares of the computer hardware maker's stock valued at $1,332,000 after buying an additional 367 shares during the last quarter. Atria Investments Inc increased its position in NVIDIA by 3.2% during the second quarter. Atria Investments Inc now owns 942,208 shares of the computer hardware maker's stock worth $148,859,000 after buying an additional 29,479 shares in the last quarter. Svenska Handelsbanken AB publ acquired a new position in shares of NVIDIA in the third quarter worth $37,316,000. Oak Ridge Investments LLC lifted its position in shares of NVIDIA by 2.2% in the third quarter. Oak Ridge Investments LLC now owns 970,860 shares of the computer hardware maker's stock valued at $181,143,000 after acquiring an additional 20,559 shares in the last quarter. Finally, Whalen Wealth Management Inc. lifted its position in shares of NVIDIA by 20.3% in the third quarter. Whalen Wealth Management Inc. now owns 36,490 shares of the computer hardware maker's stock valued at $6,808,000 after acquiring an additional 6,162 shares in the last quarter. 65.27% of the stock is currently owned by institutional investors and hedge funds. Get NVIDIA alerts: Sign ...
GAMMA Investing LLC grew its holdings in Tesla, Inc. (NASDAQ:TSLA - Free Report) by 14.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 60,182 shares of the electric vehicle producer's stock after buying an additional 7,403 shares during the period. Tesla accounts for about 1.4% of GAMMA Investing LLC's ...
GAMMA Investing LLC grew its holdings in Tesla, Inc. (NASDAQ:TSLA - Free Report) by 14.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 60,182 shares of the electric vehicle producer's stock after buying an additional 7,403 shares during the period. Tesla accounts for about 1.4% of GAMMA Investing LLC's portfolio, making the stock its 10th biggest holding. GAMMA Investing LLC's holdings in Tesla were worth $27,065,000 at the end of the most recent quarter. Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Chapman Financial Group LLC bought a new stake in Tesla in the 2nd quarter valued at $26,000. Manning & Napier Advisors LLC bought a new position in Tesla during the third quarter worth $29,000. CoreFirst Bank & Trust acquired a new position in shares of Tesla in the second quarter valued at $30,000. Turning Point Benefit Group Inc. bought a new position in shares of Tesla in the third quarter valued at about $30,000. Finally, Texas Capital Bancshares Inc TX bought a new position in shares of Tesla in the third quarter valued at about $31,000. 66.20% of the stock is currently owned by institutional investors. Get Tesla alerts: Sign Up Key Tesla News Here are the key news stories impacting Tesla this week: Analysts Set New Price Targets Several analysts recently commented on TSLA shares. JPMorgan Chase & Co. reduced their target price on shares of Tesla from $150.00 to $145.00 and set an "underweight" rating for the company in a report on Friday, January 30th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Tesla from $500.00 to $480.00 and set a "buy" rating for the company in a research report on Friday, January 30th. Wedbush restated an "outperform" rating and set a $600.00 price objective on shares of Tesla in a report on Thursday, January 29th. Royal Bank Of Canada reaffir...
We Are/DigitalVision via Getty Images Capital Southwest ( CSWC ) is a BDC, or business development company, with a high yield, but unlike a lot of high yielders, it is not a distressed lender using its high yield as bait. Nothing is further from the truth - CSWC is a well-respected premium income BDC with strong operating performance and a very long history of satisfied shareholders. CSWC currentl...
We Are/DigitalVision via Getty Images Capital Southwest ( CSWC ) is a BDC, or business development company, with a high yield, but unlike a lot of high yielders, it is not a distressed lender using its high yield as bait. Nothing is further from the truth - CSWC is a well-respected premium income BDC with strong operating performance and a very long history of satisfied shareholders. CSWC currently pays a base dividend of $0.58 per quarter, plus another $0.06 per share of specials, so its total quarterly payout comes to $0.64. Its current forward yield is 11.98%, TTM yield is ~13.2%, with consensus annual dividends between $2.40 and $2.56 per share. This makes it clearly a high-yielding BDC, but it does not come with the typical side dishes of distressed balance sheets or credit deterioration. The track record speaks for itself. CSWC has been paying dividends for 40 consecutive years. This isn’t the kind of consistency regularly seen in the BDC space, where dividend cuts are not uncommon during credit cycles. Plus, CSWC also offers periodic special dividends, which come from realized gains and excess taxable income. To be precise, its dividend is fully covered by NII. Payout ratio varies between 120% and 160%. The additional support comes from realized equity gains and accumulated undistributed taxable income (UTI). This happens because CSWC is a hybrid income model, with occasional realized gains supporting the payout level. The dividend is not fully self-funded, but given its long history, it isn’t unsafe either. So, for the dividend to remain safe, two things must keep happening: a) attractive lending spreads in the lower middle market where they operate, and b) the ability to sell equity in their private company holdings at a decent profit, either through complete/partial exits, or through recapitalization. Lower Middle Market Focus—Where the Edge Comes From CSWC lends in the lower middle market, where traditional lenders do not actively serve. Its target custom...
Philippe Aghion, who jointly won the 2025 Nobel Prize for economics, says Europe must do more to foster innovation and stop leaning on other parts of the world for technological advancement. The continent has been a "Sleeping Beauty" over the past 30 or 40 years, the French economist told Bloomberg Television. (Source: Bloomberg)
Philippe Aghion, who jointly won the 2025 Nobel Prize for economics, says Europe must do more to foster innovation and stop leaning on other parts of the world for technological advancement. The continent has been a "Sleeping Beauty" over the past 30 or 40 years, the French economist told Bloomberg Television. (Source: Bloomberg)
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Spotify . Greggory DiSalvo/iStock via Getty Images Good morning! Here's the latest in trending: Oil & gas: Trump warns about attacks on energy infrastructure, while a growing divergence is seen for crude benchmarks. Fed latest: Policy on hold + Middle East war impacts + economic pi...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Spotify . Greggory DiSalvo/iStock via Getty Images Good morning! Here's the latest in trending: Oil & gas: Trump warns about attacks on energy infrastructure, while a growing divergence is seen for crude benchmarks. Fed latest: Policy on hold + Middle East war impacts + economic picture + Powell's plans to stay in the role . On the blockchain? The SEC has approved a Nasdaq ( NDAQ ) proposal to permit stocks to be traded and settled in tokenized form . Sovereign stress Another grim fiscal milestone is making waves as the gross federal debt of the United States topped $39,000,000,000,000. This red ink arrives a mere five months after the debt breached $38T, and just seven months after it crossed the $37T mark. The amount of borrowing is absolutely staggering, with policymakers stumbling in the dark for a fiscal solution that remains nowhere in sight. Problems: Interest rate payments have become the third-largest monthly outlay for the federal government, while legislation like the "One Big Beautiful Bill" exacerbated the problem and defense expenditures are not easily contained. Bigger yet, no one wants to touch popular entitlements like Medicare, Medicaid and Social Security. Some say those programs even go way beyond what was originally envisioned, especially since the fastest-growing age group in the U.S. is people 65 and older, which will only become a larger voting base in the years to come. "Nearly three-quarters of U.S. federal spending goes on autopilot, without congressional review," Russ Greene, Managing Director of the Prime Mover Institute, wrote in a controversial piece called Total Boomer Luxury Communism . "Commentators often lament how divided Americans supposedly are. But is this true? What percentage of the federal budget do the two parties actually fight over? Only around 15%, it seems. In other words, Democrats and Republicans agree...
Remember Tesla’s electric vehicle business? It’s what makes Tesla money to invest in all of its artificial intelligence ambitions. With the first quarter coming to a close, Wall Street is updating EV sales numbers.
Remember Tesla’s electric vehicle business? It’s what makes Tesla money to invest in all of its artificial intelligence ambitions. With the first quarter coming to a close, Wall Street is updating EV sales numbers.